Fig. 4From: Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysisForest plot for risk ratios and risk differences regarding FVP in addition to SOC effectiveness for clinical improvement compared with other antivirals or SOCBack to article page